In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Asthmatx Following the Leaders In Defining Alair Sales Strategy

Executive Summary

Asthmatx is adopting the commercial strategy of high profile successes including Kyphon, Acclarent, Novacept, Fox Hollow Technologies to roll out its Alair broncial thermoplasty system, which recently received approval from the FDA.
Advertisement

Related Content

Pulmonary Device Companies Take It To The Streets - In Europe
Asthmatx Acquisition By Boston Scientific Is Source of Many Happy Returns
Asthmatx Acquisition By Boston Scientific Is Source of Many Happy Returns
Boston Sci Controls New Asthma Device Market With Acquisition
Market & Industry Briefs
Asthmatx Positive Panel Outcome Good Sign for Pulmonology Companies
Emphysema Devices Search for Breathing Room
Asthmatx Breathes Easier
Asthmatx Breathes Easier
Pulmonology: The Next Interventional Cardiology

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel